With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Gimme 5 minutes.
And you’ll know if you have an active COVID-19 infection with Abbott’s newly FDA-approved portable point-of-care test with 50K to be produced daily starting this week. | Bloomberg 2020